AbbVie heads to record rout as Allergan deal fails to end doubts
AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan, the latest merger in an industry where some of the biggest companies have been willing to pay a big premium to r…
AbbVie Inc. agreed to pay $63 billion for rival drugmaker Allergan, the latest merger in an industry where some of the biggest companies have been willing to pay a big premium to r…